“FORMULATION AND CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIERS OF TOLBUTAMIDE FOR THE TREATMENT OF TYPE II DIABETES”. 2024. CAHIERS MAGELLANES-NS 6 (2): 7092-7101. http://cahiersmagellanes.com/index.php/CMN/article/view/1040.